ThymomaFase 2NCT06248515
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Sacituzumab govitecan-hziy
73 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Pulmón y tórax73 estudios
ThymomaFase 2NCT06248515
Sacituzumab govitecan-hziy
Non Small Lung CancerFase 2NCT06582771
Sotorasib
Metastatic Non-small Cell Lung CancerFase 2NCT04410796
Osimertinib, Carboplatin, Pemetrexed
Stage III Lung Cancer AJCC v8Fase 2NCT04892953
Carboplatin, Durvalumab, Gemcitabine, Local Consolidation Therapy
Malignant NeoplasmFase 2NCT07252739
MK-1084, Pembrolizumab, Cetuximab, Sacituzumab tirumotecan (sac-TMT)
Extensive Stage Lung Small Cell CancerFase 2NCT07057791
Ivonescimab 10 mg/kg, Ivonescimab 20 mg/kg
Early Stage Lung Non-Small Cell CarcinomaFase 2NCT07718672
Biospecimen Collection, Computed Tomography, Lymph Node Biopsy, Positron Emission Tomography
Non-small Cell Lung Cancer Stage IIICFase 2NCT07250477
Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT assessment., Standard of Care
Cáncer de pulmón no microcíticoFase 2NCT07133425
SAR445877
Advanced Lung Non-Small Cell CarcinomaFase 2NCT07017829
Anti-CFH Monoclonal Antibody GT103, Biopsy Procedure, Biospecimen Collection, Computed Tomography
Metastatic NUT CarcinomaFase 2NCT07050186
Biopsy Procedure, Biospecimen Collection, Cemiplimab, Computed Tomography
Small Cell Lung CancerFase 2NCT06095505
Alisertib
Pleural Biphasic MesotheliomaFase 2NCT05647265
Nivolumab, Ipilimumab, Surgical Procedure, Computed Tomography
Lung CancerFase 2NCT05632809
NKTR-255, Durvalumab
Carcinoma de pulmón no microcíticoFase 2NCT05242965
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Sargramostim, Computed Tomography, Biopsy
Small Cell Lung CarcinomaFase 2NCT05882058
BI 764532, dose 1, BI 764532, dose 2, Ventana DLL3 RxDx assay
Lung Cancer (NSCLC)Fase 2NCT07405190
Ivonescimab, carboplatin, pemetrexed
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Fase 2NCT07452224
ILKN421H, Pembrolizumab
Extensive Stage Lung Small Cell CarcinomaFase 2NCT07423585
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test
Metastatic Non Small Cell Lung CancerFase 2NCT04614103
LN-145
Carcinoma de pulmón no microcítico metastásicoFase 2NCT05570825
Biopsy, Biospecimen Collection, Computed Tomography, CXCR1/2 Inhibitor SX-682
Cáncer de pulmón no microcíticoFase 2NCT07603856
Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab), Investigator Choice Chemotherapy (for example docetaxel with or without ramucirumab, gemcitabine, or other National Comprehensive Cancer Network (NCCN)-recommended treatments), Ablative Hypofractionated Radiotherapy
Cáncer de pulmón no microcíticoFase 2NCT06364917
Pembrolizumab, Carboplatin, Paclitaxel, Pemetrexed
Lung CancerFase 2NCT05419076
Stereotactic Radiosurgery, Cerebrospinal fluid collection